Rheumatoid Arthritis Diagnosis Market – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034
Overview
Rheumatoid Arthritis Diagnosis Market size is expected to reach US$ 51171.24 Mn. by year 2034 at a CAGR of 4.60% during the forecast period.
The global Rheumatoid Arthritis Diagnosis market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Rheumatoid Arthritis Diagnosis market report also provides trends by market segments, technology, and investment with a competitive landscape.
Rheumatoid Arthritis Diagnosis Market Size, Share and Growth Analysis
To know about the Research Methodology :- Request Free Sample Report
Rheumatoid Arthritis Diagnosis Market Overview
Rheumatoid arthritis (RA) is a type of chronic autoimmune disease. In this condition person's immune system mistakes the body's healthy tissues as a foreign invader. It's also a systemic disease meaning it can affect and spread in the whole body. Symptoms of RA include inflammation, swelling, pain, and others around joints as well as other body organs. Firstly, it affects hands and feet. However, it can affect any joint. Some of its major symptoms are pain & stiffness around one or more joints, symmetrical joint involvement, and problems around joint structure, pain, dizziness while walking, constant feeling or sense of tiredness, fever, loss of mobility, weight loss & weakness.
Rheumatoid arthritis can be of different types such as seropositive RA, seronegative RA, and juvenile idiopathic arthritis (JIA). It affects adults of any age group but people ranging between the age of 40 to 60 are diagnosed with RA most and is more common in women than men. Patient symptoms govern the diagnosis of RA, a physical examination, results of X-ray and blood & urine test.
Rheumatoid Arthritis Diagnosis Market Dynamics
Increasing aging and geriatric population coupled, the prevalence of rheumatoid arthritis globally are the major factors that are driving the market growth. For instance, as per the data of the National Center for Biotechnology of the US, the number of people suffering from RA is anticipated to reach 579,915 by 2034 from 422,309 in 2015. Including the expenditure of 273 MN on modifying antirheumatic drugs. Although there is no permanent cure for rheumatoid arthritis, early detection & proper treatment such as surgery changed lifestyle can limit & reduce the damage of joints. Moreover, high consumption of fried and processed food that includes artificial flavor, chemicals, and other food additives as an ingredient can cause RA as well. Thus, the market for RA diagnosis is expected to record high growth.
Additionally, increased obesity among people and a rising number of people addicted to smoking cigarettes impacted in a way or the growth of the RA diagnosis market. Cigarette smoking reportedly increases the risk of rheumatoid arthritis plus obsessed people are at great risk of contracting this disease than people whose weight is high. As per the made created by Dr. Finkelisten and his assistants at duke & the center for disease control projected that the rate of obesity in the US will be at 40% by 2034. Increased knowledge of geriatric people about Rheumatoid arthritis combined with an adequate healthcare system is impacting positively on the market growth as well.
However, certain factors such as the high cost related to the diagnostic test kits, various government rules & regulations, and delays in the approval of drugs for the medications are restraining the market growth.
Rheumatoid Arthritis Diagnosis Market Segment Analysis
Based on the method, the segment of imaging test is termed as the most specific and popular test for diagnosing and treating rheumatoid arthritis. Doctors may choose this test to track the progression of RA in the patient's body. MRI and CT scan assist the doctor in identifying severeness of the diseases. Although, every test is unique for diagnostic purposes. Moreover, people suffering from RA reportedly have elevated C - reactive protein (CRP) level or sed rate for which a blood test is performed to detect the exact level. Whereas, the antinuclear body is another common laboratory test used for diagnosing RA. This test is performed to identify various levels of antibodies that may be present in a patient's blood with some type of arthritis.
Other tests, like the uric acid test that helps in determining the level of uric acid in the body, leads to the formulations of gout in the body which is also an inflammatory disorder and is not autoimmune. Uric acids are present in food & drinks taking specific medications can also increase the level of uric acid in the body. Uric acid gets deposited in synovial tissues especially, in the elbow, hand, and feet. Thus, propelling RA diagnostic market growth
By end-user, the market is categorized into hospitals, diagnostic clinics, and ambulatory surgical centers. The segment of hospital dominated the majority market due to preference of patients preferring visits to the hospital for diagnostic and treatment of RA in the body. Moreover, advancement in the technology and adoption philosophy or Treat to Target impacted positively on the growth of the market. Whilst, diagnostic clinics have also seen growth in recent years because of the increased number of people visiting diagnostic clinics to detect the RA these private labs are easy to reach and provides quicker results followed by the ambulatory surgical centers where a patient undergoes the operation and is discharged on the same day. Though, most of the people suffering from RA don't require surgery.
Rheumatoid Arthritis Diagnosis Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 18 June 2025 | Scipher Medicine | Scipher Medicine unveiled its new AI-driven RA Response Calculator at EULAR 2025 to predict rheumatoid arthritis treatment response using real-world clinico-genomic patient data. | The tool enhances precision diagnostic decision-making by eliminating trial-and-error treatment pathways and improving therapeutic response evaluation for RA patients. |
| 15 October 2025 | Augurex Life Sciences Corp. | Augurex expanded access to its JOINTstat® diagnostic test for rheumatoid arthritis through a partnership with MitogenDx. | The collaboration accelerates early detection of rheumatoid arthritis by broadening access to blood-based 14-3-3eta biomarker testing across clinical networks. |
| 17 November 2025 | Augurex Life Sciences Corp. | Augurex partnered with Sonic Reference Laboratory to launch its 14-3-3eta diagnostic blood test across the United States. | This nationwide launch improves diagnostic sensitivity and clinical monitoring for seronegative rheumatoid arthritis patients using specialized biomarker testing. |
| 10 March 2026 | Exagen Inc. | Exagen commercially launched novel rheumatoid arthritis biomarkers, including anti-RA33 and anti-PAD4, integrated into its AVISE CTD testing platform. | The introduction of these targeted biomarkers enhances diagnostic specificity, allowing clinicians to identify seronegative RA patients and improve diagnostic accuracy. |
Rheumatoid Arthritis Diagnosis Market Regional Insights:
Europe and North America dominated the global Rheumatoid arthritis diagnosis market. As per MMR the report, the prevalence of RA is high in both regions. According to the report published By the (CDC) Center for Disease Control and Prevention in states that around 54 million people were suffering from rheumatoid arthritis in the US alone. This high number of patients and prevalence of RA requires effective diagnosis and treatment of RA. Thus, the market for RA is anticipated to witness substantial growth in the forecast period. Moreover, the availability of adequate RA testing kits for the diagnostic clinics and hospitals High commercialization of rapid rheumatoid arthritis is anticipated to increase the demand for monitoring test kits further impacted positively on the region's market.
Currently, In Asia Pacific, the prevalence of RA is relatively low in developing and developed nations. Though, the rising geriatric population in countries like China and Japan due to their child policy is projected to increase the prevalence of RA in the region and eventually leading towards the market growth of the RA diagnostic. Additionally, with the rising case, the demand for RA testing kits has surged due to which t commercialization has increased through distribution channels to make sure kits are available in a possible way combined with the developed healthcare system and increased investment in the field of diagnostics impacting positively on the market growth. With China, Japan, and India contributing most to the region's market growth.
The objective of the report is to present a comprehensive analysis of the Global Rheumatoid Arthritis Diagnosis market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Rheumatoid Arthritis Diagnosis Market dynamics, structure by analyzing the market segments and project the Global Rheumatoid Arthritis Diagnosis Market size. Clear representation of competitive analysis of key players by Method, price, financial position, Method portfolio, growth strategies, and regional presence in the Global Rheumatoid Arthritis Diagnosis Market make the report investor’s guide.
Rheumatoid Arthritis Diagnosis Market Scope: Inquire before buying
| Global Rheumatoid Arthritis Diagnosis Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US$ 34138.21 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 4.60% | Market Size in 2034: | US$ 51171.24 Mn. |
| Segments Covered: | by Method | Serology Tests Erythrocyte Sedimentation rate Anti-Cyclic Citrullinated Peptide Rheumatoid Factor Antinuclear Antibody Image Testing |
|
| by End User | Hospitals Diagnostic Clinics Ambulatory Surgical Centers |
||
Rheumatoid Arthritis Diagnosis Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Rheumatoid Arthritis Diagnosis Market Key Players
1. Antibodies Inc.
2. Euro Diagnostica AB
3. Qiagen NV
4. Siemens Healthcare GmbH
5. Bio Rad Laboratories Inc.
6. Genway Biotech, Inc.
7. Abbott Diagnostics
8. Beckman Coulter, Inc.,
9. F. Hoffmann-La Roche Ltd.
10.Thermo Fisher Scientific Inc
11.Danaher Corporation
12.Fast Track Diagnostics
13.Alere, Inc.
14.Quest Diagnostics
Frequently Asked Questions:
1. Which region has the largest share in Global Rheumatoid Arthritis Diagnosis Market?
Ans: Asia Pacific region holds the highest share in 2025.
2. What is the growth rate of Global Rheumatoid Arthritis Diagnosis Market?
Ans: The Global Rheumatoid Arthritis Diagnosis Market is growing at a CAGR of 4.60% during forecasting period 2026-2034.
3. What is scope of the Global Rheumatoid Arthritis Diagnosis market report?
Ans: Global Rheumatoid Arthritis Diagnosis Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Rheumatoid Arthritis Diagnosis market?
Ans: The important key players in the Global Rheumatoid Arthritis Diagnosis Market are – Antibodies Inc., Euro Diagnostica AB, Qiagen NV, Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Genway Biotech, Inc., Abbott Diagnostics, Beckman Coulter, Inc.,, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc, Danaher Corporation, Fast Track Diagnostics, Alere, Inc., Quest Diagnostics, and Others.
5. What is the study period of this market?
Ans: The Global Rheumatoid Arthritis Diagnosis Market is studied from 2020 to 2034.